Stockholders' Equity	9 Months Ended
Sep. 30, 2019
Equity [Abstract]
Stockholders' Equity	NOTE 13: STOCKHOLDERS’ EQUITY On January 31, 2018, our Board of Directors authorized a repurchase of up to $250 million of our shares of common stock under a share repurchase program. This share repurchase program has no expiration date but may be suspended or terminated by our Board of Directors at any time. Our Board of Directors authorized and directed management, working with the Executive Committee of our Board of Directors, to affect the share repurchase program in compliance with applicable legal requirements. The Company did not repurchase any shares of outstanding common stock during the three and nine months ended September 30, 2019, respectively, and during the three months ended September 30, 2018 under the share repurchase program. During the nine months ended September 30, 2018, we repurchased 2,582,198 shares of outstanding common stock under the share repurchase program at an aggregate cost of $100 million, or an average share price of $38.73, exclusive of fees and commissions. As of both September 30, 2019 and December 31, 2018, there were 12,056,688 shares of the Company’s common stock held in treasury with an aggregate cost of $547 million. As of September 30, 2019, we had a remaining $150 million available to repurchase shares of our common stock under this share repurchase program. On November 1, 2019, our Board of Directors authorized the repurchase of an additional $100 million of shares of our common stock under our existing share repurchase program, which increased the amount available to the Company under this share repurchase program to $250 million.

Stockholders' Equity

9 Months Ended

Sep. 30, 2019

NOTE 13: STOCKHOLDERS’ EQUITY

On January 31, 2018, our Board of Directors authorized a repurchase of up to $250 million of our shares of common stock under a share repurchase program. This share repurchase program has no expiration date but may be suspended or terminated by our Board of Directors at any time. Our Board of Directors authorized and directed management, working with the Executive Committee of our Board of Directors, to affect the share repurchase program in compliance with applicable legal requirements.

The Company did not repurchase any shares of outstanding common stock during the three and nine months ended September 30, 2019, respectively, and during the three months ended September 30, 2018 under the share repurchase program. During the nine months ended September 30, 2018, we repurchased 2,582,198 shares of outstanding common stock under the share repurchase program at an aggregate cost of $100 million, or an average share price of $38.73, exclusive of fees and commissions. As of both September 30, 2019 and December 31, 2018, there were 12,056,688 shares of the Company’s common stock held in treasury with an aggregate cost of $547 million. As of September 30, 2019, we had a remaining $150 million available to repurchase shares of our common stock under this share repurchase program.

On November 1, 2019, our Board of Directors authorized the repurchase of an additional $100 million of shares of our common stock under our existing share repurchase program, which increased the amount available to the Company under this share repurchase program to $250 million.